We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Top Factors Driving Global POC Glucose Monitoring Devices Market

By LabMedica International staff writers
Posted on 23 Feb 2018
The global market for POC blood glucose monitoring devices is expected to grow at a CAGR of over 8% during the period 2018-2022, driven mainly by public and private initiatives to reduce diabetic cases. More...
These are the latest findings of Technavio Research, (London, UK), a global technology research and advisory company.

There has been an increase in the incidence of lifestyle diseases such as diabetes, which is of three types: Type 1, Type 2, and gestational diabetes (diabetes during pregnancy). The CDC estimates that, as of 2017, more than 30 million individuals in the US had diabetes, out of which over 95% had Type 2 diabetes. Heredity, obesity, unhealthy diet, and sedentary lifestyle are the main factors responsible for Type 2 diabetes. The growing aged population and increasing number of overweight individuals is leading to a higher number of adults suffering from diabetes.

In order to prevent or delay Type 2 diabetes, the US government is introducing several programs under the national diabetes prevention program in association with the CDC, such as the CDC-recognized diabetes prevention lifestyle change program. The increase in such public and private initiatives to reduce the number of diabetic cases will have the highest positive impact on the growth of the POC blood glucose monitoring devices market.

Based on product, the global POC blood glucose monitoring devices market was dominated by the consumables segment in 2017 with the largest share of 67%. The largest share of the consumables segment was due to continuous usage of consumables while performing blood glucose monitoring tests, especially for diabetic patients. The growing preference for disposable consumables to reduce the risk of contamination is expected to further boost the demand for consumables among various healthcare centers. Based on end-user, the hospitals and clinics segment accounted for the largest share of the blood glucose monitoring devices market in 2017 due to the increasing number of diabetic cases in the US.

The POC blood glucose monitoring devices market is witnessing growth in the Americas due to increasing focus on advanced technologies and development of non-invasive wearable POC glucose monitoring devices. The market for blood glucose monitoring devices in the region will continue to grow during the period 2018-2022, driven by the availability of favorable reimbursements for POC blood glucose monitoring devices and increasing number of FDA approvals for technologically-advanced products. Additionally, the increasing cases of hyperglycemia will lead to an increase in the need for blood glucose tests and higher demand for POC blood glucose monitoring devices in the region over the next five years.

“The increasing diabetic patient pool also increases the economic burden due to which several public and private organizations around the world are engaged in activities to increase awareness and reduce the incidence of Type 2 diabetes which can be controlled or averted by adopting lifestyle changes. These awareness initiatives augur well for the growth of the market as they will encourage increased adoption of POC blood glucose monitoring devices,” said a senior analyst at Technavio.

Related Links:
Technavio Research


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.